v. 2, n. 3, (2021)
Review

Major Approaches to the Dosage of Vitamin D in the Elderly: A Systematic Review

Moniele Matos Cadamuro
MANZINI CLINIC - General Medical Practice, Nutrology, and Health Sciences, Votuporanga, Sao Paulo, Brazil.
Durval Ribas Filho
ABRAN - Associação Brasileira de Nutrologia /Brazilian Association of Nutrology, Catanduva/SP, Brazil.

Published 2021-06-09

Keywords

  • Elderly,
  • Vitamin D,
  • 25 (OH) D,
  • Hypovitaminosis,
  • Immunity,
  • Inflammatory Process
  • ...More
    Less

How to Cite

Cadamuro, M. M., & Filho, D. R. (2021). Major Approaches to the Dosage of Vitamin D in the Elderly: A Systematic Review. MedNEXT Journal of Medical and Health Sciences, 2(3), 1–5. https://doi.org/10.34256/mdnt2131

Abstract

Introduction: In the scenario of vitamin D deficiency, this incident is prevalent and with risks to public health in the world, reaching approximately 90% of individuals. Hypovitaminosis D can cause, mainly in the elderly, lower bone mineral density, fractures, muscle weakness, falls, and acute respiratory infection. Objective: To evaluate the main clinical results on vitamin D levels in the elderly, as well as to analyze which daily or weekly dose of vitamin D is most effective in the elderly in reducing the number of falls and fractures. Methods: The present study developed a systematic review, addressing randomized clinical studies, diverse clinical studies, systematic reviews, meta-analysis, and the latest international consensus, following the rules of PRISMA. Results and Conclusion: A total of 152 articles were found involving the dosage and the impact of vitamin D in the elderly. In total, 72 articles were evaluated in full and 30 were included. According to the main literary findings, vitamin D deficiency implies problems with mineralization and bone mineral density, causing fractures and an increase in the number of elderly falls. In this sense, SBEM recommends maintaining vitamin D concentrations above 30 ng/mL. Also, vitamin D deficiency points to the occurrence of neurological diseases such as cognitive decline, risk of Alzheimer's disease, and depression. In the current scenario of the pandemic, vitamin D points as an important modulator of the immune system, and its deficiency promotes the unregulated release of cytokines, leading to complications in patients with COVID-19.

References

  1. OMS/OPAS. Organização Mundial de Saúde/Organização Pan-Americana da Saúde. Disponível em: https://www.paho.org/bra/index.php?option=com_docman&view=document&layout=default&alias=478-a-eficacia-calcio-e-vitamina-d-na-prevencao-fraturas-osseas-v-2-n-10-2005-8&category_slug=uso-racional-medicamentos 685&Itemid=965. Acessado em: 20 de fevereiro de 2020.
  2. A. Giustina, R.A. Adler, N. Binkley, J. Bollerslev, R. Bouillon, B. Dawson-Hughes , P.R. Ebeling, D. Feldman, A.M. Formenti, M. Lazaretti-Castro, C. Marcocci, R. Rizzoli, C.T. Sempos, J.P. Bilezikian, Consensus statement from 2nd International Conference on Controversies in Vitamin D, Reviews in Endocrine and Metabolic Disorders, 21 (2020) 89-116.
  3. P. Lips, K.D. Cashman, C. Lamberg-Allardt, H.A. Bischoff-Ferrari, B. Obermayer-Pietsch, M.L. Bianchi, J. Stepan, G. El-Hajj Fuleihan, Roger Bouillon, Current vitamin D status in European and Middle East countries and strategies to prevent vitamin D deficiency: a position statement of the European Calcified Tissue Society, European Journal of Endocrinology, 180 (2019) 23-54.
  4. S.J. Wimalawansa, M.S. Razzaque, N.M. Al-Daghri, Calcium and vitamin D in human health: Hype or real?, Journal of Steroid Biochemistry and Molecular Biology, 180 (2018) 4–14.
  5. R. Bouillon, Comparative analysis of nutritional guidelines for vitamin D, Nature Reviews Endocrinology, 13 (2017) 466-79.
  6. N. Binkley, B. Dawson-Hughes, R. Durazo-Arvizu, M. Thamm, L. Tian, J.M. Merkel, J.C. Jones, G.D. Carter, C.T. Sempos, Vitamin D measurement standardization: The way out of the chaos, Journal of Steroid Biochemistry and Molecular Biology, 173 (2017) 117–21.
  7. M. Herrmann, C_J.L. Farrell, I. Pusceddu, N. Fabregat-Cabello, E. Cavalier, Assessment of vitamin D status - a changing landscape, Clinical Chemistry and Laboratory Medicine, 55 (2017) 3–26.
  8. C.T Sempos, A.C. Heijboer, D.D. Bikle, J. Bollerslev, R. Bouillon, P.M. Brannon, H.F. DeLuca, G. Jones, C.F. Munns, J.P. Bilezikian, A. Giustina , N. Binkley, Vitamin D assays and the definition of hypovitaminosis D: results from the First International Conference on Controversies in Vitamin D, British Journal of Clinical Pharmacology, 84 (2018) 2194–2207.
  9. R.A. Durazo-Arvizu, L. Tian, S.P.J. Brooks, K. Sarafin, K.D. Cashman, M. Kiely, J. Merkel, G.L. Myers, P.M. Coates, C.T. Sempos, The Vitamin D Standardization Program (VDSP) Manual for Retrospective Laboratory Standardization of Serum 25-Hydroxyvitamin D Data, Journal of AOAC International, 100 (2017) 1234–1243.
  10. R. Bouillon, C. Marcocci, G. Carmeliet, Daniel Bikle, J. H. White, B. Dawson-Hughes, P.Lips, C.F. Munns, Marise Lazaretti-Castro, A. Giustina, J. Bilezikian, Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding Questions, Endocrine Reviews, 40 (2019) 1109-1151.
  11. L.S. Bislev, L. Langagergaard Rødbro, T. Sikjær, L. Rejnmark, Effects of Elevated Parathyroid Hormone Levels on Muscle Health, Postural Stability and Quality of Life in Vitamin D-Insufficient Healthy Women: A Cross-Sectional Study, Calcified Tissue International, 105 (2019) 642-650.
  12. D. Moher, A. Liberati, J. Tetzlaff, D.G. Altman, The PRISMA Group Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement, PLOS Medicine, 6 (2009) e1000097.
  13. H. Balshem, M. Helfand, H.J. Schünemann, A.D. Oxman, R. Kunz, J. Brozek, Vist GE, Falck-Ytter Y, Meerpohl J, Norris S, Guyatt GH, Grade guidelines: 3 ratng the quality of evidence. Journal of Clinical Epidemiology, Maryland Heights, 64(4) (2011) 401-406.
  14. J. Higgins, S. Green, (2011) Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0, The Cochrane Collaboration.
  15. E.M. Lewiecki, Nonresponders to osteoporosis therapy, Journal of Clinical Densitometry, 6 (2003) 307-314.
  16. S. Adami, S. Giannini, G. Bianchi, L. Sinigaglia, O. Di Munno, C.E. Fiore, S. Minisola, M. Rossini, Vitamin D status and response to treatment in post-menopausal osteoporosis, Osteoporosis International, 20 (2009) 239-44.
  17. S Shab-Bidar, S.P. Bours, P.P. Geusens, R.Y. Van der Velde, M.J. Janssen, J.P. Van den Bergh, Suboptimal effect of different vitamin D3 supplementations and doses adapted to baseline serum25(OH)D on achieved 25(OH)D levels in patients with a recent fracture: a prospective observational study, journal of the European Society of Endocrinology, 169 (2013) 597-604.
  18. I.J. Zotarelli Filho, A.V.G. Ramirez, D. Ribas Filho, Major Meta-Analysis, Randomized Clinical Studies, and International Consensus on Serum Levels and Importance of Supplementing Vitamin D: State of the art. MedNEXT Journal of Medical and Health Sciences, 2 (2021) 54-66.
  19. A.C. Looker, Serum 25¬hydroxyvitamin D and risk of major osteoporotic fractures in older U.S. adults, Journal of Bone and Mineral Research, 28 (2013) 997-1006.
  20. H.A. Bischoff-Ferrari, B. Dawson-Hughes, H.B. Staehelin, J.E. Orav, A.E. Stuck, R. Theiler, J.B. Wong, A. Egli, D.P. Kiel, J. Henschkowski, Fall prevention with supplemental and active forms of vitamin D: a meta¬-analysis of randomised controlled trials, British medical journal, 339 (2009) 3692.
  21. Y. Noguchi, H. Kawate, M. Nomura, R. Takayanagi, Eldecalcitol for the treatment of osteoporosis, Clinical interventions in aging, 8 (2013) 1313-1321.
  22. H. Hagino, T. Takano, M. Fukunaga, M. Shiraki, T. Nakamura, T. Matsumoto, Eldecalcitol reduces the risk of severe vertebral fractures and improves the health¬related quality of life in patients with osteoporosis, Journal of bone and mineral metabolism, 31 (2013) 183-189.
  23. T. Nakamura, T. Takano, M. Fukunaga, M. Shiraki, T. Matsumoto, Eldecalcitol is more effective for the prevention of osteoporotic fractures than alfacalcidol, Journal of bone and mineral metabolism, 31 (2013) 417-422.
  24. H.A. Bischoff-Ferrari, Should vitamin D administration for fracture prevention be continued? A discussion of recent meta-analysis findings, Zeitschrift für Gerontologie und Geriatrie, 52 (2019) 428-432.
  25. A. Zittermann, S. Pilz, Vitamin D and Cardiovascular Disease: An Update, Anticancer Research, 39 (2019) 4627-4635.
  26. S. Thanapluetiwong, A. Chewcharat, K. Takkavatakarn, K. Praditpornsilpa, S. Eiam-Ong, P. Susantitaphong, Vitamin D supplement on prevention of fall and fracture: A Meta-analysis of Randomized Controlled Trials. Medicine (Baltimore), 99 (2020) e21506.
  27. Q. Wang, D. Yu, J. Wang, S. Lin, Association between vitamin D deficiency and fragility fractures in Chinese elderly patients: a cross-sectional study, Annals of Palliative Medicine, 9 (2020) 1660-1665.
  28. D.J. Llewellyn, I.A. Lang, K.M. Langa, G. Muniz-Terrera, C.L. Phillips, A. Cherubini, Vitamin D and risk of cognitive decline in elderly persons, Archives of Internal Medicine, 170 (2010) 1135-41.
  29. S. Nagpal, S. Na, R. Rathachalam, Non calcemic actions of vitamina D receptor ligands, Endocrine Reviews, 26 (2005) 662-687.
  30. R.K. Visweswaran, H. Lekha, Extraskeletal effects and manifestations of Vitamin D deficiency, Indian Journal of Endocrinology and Metabolism, 17 (2013) 602-610.
  31. C. Annweiler, M. Beaudenon, J. Gautier, R. Simon, V. Dubée, J. Gonsard, E. Parot-Schinkel, COvid-19 and high-dose VITamin D supplementation TRIAL in high-risk older patients (COVIT-TRIAL): study protocol for a randomized controlled trial, Trials, 21 (2020) 1031.
  32. F. Macaya, C.E. Paeres, A. Valls, A. Fernández-Ortiz, J.G.D. Castillo, F.J. Martín-Sánchez, I. Runkle, M.A.R. Herrera, Interaction between age and vitamin D deficiency in severe COVID-19 infection, Nutricion Hospitalaria, 37 (2020) 1039-1042.
  33. A.K.J. Mandal, V. Baktash, T. Hosack, C.G. Missouris, Vitamin D status and COVID-19 in older adults, Aging Clinical and Experimental Research, 32 (2020) 2425-2426.